AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption at Raymond James Conference [Yahoo! Finance]
Axogen, Inc. (AXGN)
Last axogen, inc. earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axogeninc.com
Company Research
Source: Yahoo! Finance
and hesitant physicians, and lets the company consolidate to a single biologics quality system while pursuing new controlled studies. Management guided to at least 18% revenue growth (about $266 million) with 74%–76% gross margin and net free cash flow positive for the year, and completed a $142 million financing (net $133M) that paid down debt and bolsters the balance sheet. AxoGen sees adoption constrained mainly by awareness and payer coverage — it reports roughly a 35% gap in commercial lives covered but expects updates from major payers and targets growth from extremities, breast reconstruction and head/neck markets, with AVANCE driving ~60% of revenue. Interested in AxoGen, Inc.? Here are five stocks we like better. AxoGen (NASDAQ:AXGN) used its presentation at the 47th annual Raymond James Institutional Investors Conference to outline its mission to make restoration of peripheral nerve function an expected standard of care, while also providing updates on growth expecta
Show less
Read more
Impact Snapshot
Event Time:
AXGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXGN alerts
High impacting Axogen, Inc. news events
Weekly update
A roundup of the hottest topics
AXGN
News
- AxoGen, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- A Look At Axogen (AXGN) Valuation After Recent Share Price Pullback And BLA Expectations [Yahoo! Finance]Yahoo! Finance
- Axogen (AXGN) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Axogen targets at least 18% revenue growth in 2026 as BLA milestone strengthens market position [Seeking Alpha]Seeking Alpha
- AxoGen Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
AXGN
Earnings
- 2/24/26 - Beat
AXGN
Sec Filings
- 3/2/26 - Form 4
- 3/2/26 - Form 4
- 3/2/26 - Form 4
- AXGN's page on the SEC website